Nodexus, a startup originating from UC Berkeley and Stanford's StartX accelerator, focuses on commercializing cutting-edge technologies for advanced workflows in gene editing, cancer biology, agriculture, and more. Their flagship product, the NX One, is an affordable and flexible single-cell sorting and dispensing system designed to make high-precision cellular analysis accessible to a broader range of researchers and institutions.
The company has attracted notable figures in the field of flow cytometry to its Scientific Advisory Board, enhancing its expertise and credibility. Nodexus has achieved significant milestones, including the successful deployment of its technology in various high-impact research areas. By democratizing access to advanced cellular analysis tools, Nodexus is making a substantial impact on scientific research and innovation across multiple disciplines.
